OraSure Technologies | OSUR - Des Atouts





Des Atouts Changement Date
Agilent USD 13.07B 252M 2026-03
AngioDynamics USD 269.68M 4.04M 2025-09
Becton, Dickinson and Co. USD 50.83B 4.01B 2026-03
Bio Techne USD 2.55B 27.9M 2026-03
Bio-Rad Laboratories USD 9.79B 786.5M 2026-03
Bruker USD 6.13B 110.7M 2026-03
Cerus USD 221.86M 6.67M 2025-12
Charles River Laboratories USD 7.73B 594.89M 2026-03
Danaher USD 83.54B 80M 2026-03
Dentsply International USD 5.23B 200M 2026-03
Dexcom USD 6.63B 293.4M 2026-03
Illumina USD 6.56B 85M 2026-03
Integra LifeSciences USD 3.58B 24.28M 2026-03
Intuitive Surgical USD 20.11B 347.7M 2026-03
IQVIA Holdings USD 29.68B 269M 2026-03
Mesa Laboratories USD 434.85M 4.5M 2025-12
Mettler Toledo International USD 3.67B 43.73M 2026-03
Myriad Genetics USD 673.7M 32.9M 2026-03
OraSure Technologies USD 379.17M 24M 2026-03
Quidel USD 5.63B 140.6M 2026-03
Repligen USD 2.93B 18.93M 2026-03
Revvity USD 12B 171.82M 2026-03
STAAR Surgical USD 451.12M 560K 2026-03
Thermo Fisher Scientific USD 113.28B 2.94B 2026-03
Trinity Biotech USD 105.16M 1.45M 2025-12
Waters USD 24.53B 19.45B 2026-03